Found: 24
Select item for more details and to access through your institution.
Priorities in Parkinson's disease research.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Evaluation of the PREDIGT score's performance in identifying newly diagnosed Parkinson's patients without motor examination.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00360-5
- By:
- Publication type:
- Article
Diurnal and intersubject variability of cerebrospinal fluid biomarkers, Aβ-40/42, alpha-synuclein and DJ-1 in healthy volunteers
- Published in:
- 2012
- By:
- Publication type:
- Abstract
P3-444: Proteasomal inhibition increases alpha-synuclein levels in an amyloid-beta-dependent manner
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-231: Biochemical and histological studies of leucine rich repeat kinase 2 (LRRK2)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-444: Proteasomal inhibition increases alpha-synuclein levels in an amyloid-beta-dependent manner
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P3-231: Biochemical and histological studies of leucine rich repeat kinase 2 (LRRK2)
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0080705
- By:
- Publication type:
- Article
Precision medicine for Parkinson’s disease: The subtyping challenge.
- Published in:
- Frontiers in Aging Neuroscience, 2022, v. 14, p. 1, doi. 10.3389/fnagi.2022.1064057
- By:
- Publication type:
- Article
Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT<sub>2A</sub> receptor-mediated stimulation of oxytocin.
- Published in:
- Synapse, 2005, v. 58, n. 2, p. 102, doi. 10.1002/syn.20187
- By:
- Publication type:
- Article
Parkinson's Disease Biomarkers: Resources for Discovery and Validation.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 1, p. 241, doi. 10.1038/npp.2013.246
- By:
- Publication type:
- Article
Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau<sub>181</sub>, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease.
- Published in:
- JAMA Neurology, 2013, v. 70, n. 10, p. 1277, doi. 10.1001/jamaneurol.2013.3861
- By:
- Publication type:
- Article
Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting.
- Published in:
- Innovations in Clinical Neuroscience, 2020, v. 17, n. 1/3, p. 14
- By:
- Publication type:
- Article
Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable Sensors.
- Published in:
- Sensors (14248220), 2022, v. 22, n. 18, p. 6831, doi. 10.3390/s22186831
- By:
- Publication type:
- Article
Finding useful biomarkers for Parkinson's disease.
- Published in:
- Science Translational Medicine, 2018, v. 10, n. 454, p. 1, doi. 10.1126/scitranslmed.aam6003
- By:
- Publication type:
- Article
Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
- Published in:
- Movement Disorders, 2020, v. 35, n. 11, p. 1999, doi. 10.1002/mds.28206
- By:
- Publication type:
- Article
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 6, p. 935, doi. 10.1007/s00401-016-1552-2
- By:
- Publication type:
- Article
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Funding of Parkinson research from industry and US federal and foundation sources.
- Published in:
- Movement Disorders, 2009, v. 24, n. 5, p. 731, doi. 10.1002/mds.22446
- By:
- Publication type:
- Article